The Nordstrom Beat the Bridge to Beat Diabetes is a fundraiser for JDRF — the leading global organization funding type 1 diabetes (T1D) research. The event consists of an 8K run and wheelchair race, a 3-mile walk, a 1-mile fun run, and the Diaper Derby for toddlers. The event is called Beat the Bridge because in a typical year, the course travels over Seattle’s University Bridge, which is raised during the race. Participants try to cross the bridge before it is raised. Those who don't beat the bridge must wait, with a live band and entertainment, for the bridge to come back down. After a few minutes, the bridge lowers and everyone can finish the race. Since the first Beat the Bridge race in 1983, Nordstrom has partnered with JDRF to raise funds to cure, prevent and better treat T1D. Beat the Bridge is part of the JDRF One Walk program, which holds annual charitable walks in more than 200 locations in 13 countries. JDRF One Walk has raised more than $1 billion for T1D research and we are proud to currently hold the number one position as the largest Walk in the country! We hope you will join us on May 16, 2021 for the 39th Annual Nordstrom Beat the Bridge to Beat Diabetes.
In 2020, Beat the Bridge went virtual in response to the COVID-19 pandemic. In 2021, with respect to the health and safety of our community, JDRF and Nordstrom have decided to reimagine the 2021 Nordstrom Beat the Bridge from an in-person event to a virtual one. Hit the pavement in your neighborhood for the 39th Annual Nordstrom Beat the Bridge to Beat Diabetes benefiting JDRF on May 16! What does that mean exactly? On the morning of Sunday, May 16th, instead of gathering at Husky Stadium, we encourage everyone to run, walk, hop, or skip wherever they are. While we may be moving through different streets, we remain committed to Turning Type One into Type None!
About JDRF & Type 1 Diabetes
Type 1 diabetes (T1D) is a chronic, life-threatening autoimmune disease that is currently unpreventable. It has nothing to do with diet or lifestyle and occurs when the immune system mistakenly attacks insulin-producing beta cells within the pancreas and begins killing them off. Eventually the pancreas isn’t able to produce enough insulin to control the blood-sugar spikes that happen after eating. Today, people with T1D rely on insulin therapy to control their blood sugar levels. Insulin therapy is imperfect, however, and even with advances in care, most people still experience life-threatening blood-sugar highs and lows. 1.6 million Americans currently have type 1 diabetes (T1D), and the disease costs about $15 billion each year to treat. Finding ways to prevent this disease is central to saving lives and reducing healthcare costs. With T1D there are no days off, and there is no cure. That's why since 1970, JDRF has sponsored nearly $2 billion in scientific research in 17 countries. We won't stop until we create a world without T1D.